Global Medical Wound Care Biologics Supply, Demand and Key Producers, 2023-2029

Description

The global Medical Wound Care Biologics market size is expected to reach $ 8021.6 million by 2029, rising at a market growth of 10.2% CAGR during the forecast period (2023-2029).

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Medical wound care biologics are products derived from biological sources that are used in the treatment of wounds to promote healing and tissue regeneration. These biologics are typically composed of living cells, proteins, growth factors, or other biologically active substances that are applied to the wound to facilitate the healing process.

This report studies the global Medical Wound Care Biologics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Medical Wound Care Biologics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Medical Wound Care Biologics that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Medical Wound Care Biologics total market, 2018-2029, (USD Million)
Global Medical Wound Care Biologics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Medical Wound Care Biologics total market, key domestic companies and share, (USD Million)
Global Medical Wound Care Biologics revenue by player and market share 2018-2023, (USD Million)
Global Medical Wound Care Biologics total market by Type, CAGR, 2018-2029, (USD Million)
Global Medical Wound Care Biologics total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Medical Wound Care Biologics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Smith & Nephew Plc, Stryker Corporation, MIMEDX, Organogenesis, Bioventus, Skye Biologics, Anika Therapeutics, Alphatec Holdings and Kerecis, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Medical Wound Care Biologics market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Medical Wound Care Biologics Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Medical Wound Care Biologics Market, Segmentation by Type
    Biologic Skin Substitutes
    Enzyme Based Formulations
    Growth Factors

Global Medical Wound Care Biologics Market, Segmentation by Application
    Acute Wounds
    Chronic Wounds
    Surgical Wounds

Companies Profiled:
    Smith & Nephew Plc
    Stryker Corporation
    MIMEDX
    Organogenesis
    Bioventus
    Skye Biologics
    Anika Therapeutics
    Alphatec Holdings
    Kerecis
    Integra LifeSciences
    Orthocell
    3M Company
    Convatec Group
    Coloplast
    Cardinal Health
    Mölnlycke

Key Questions Answered
1. How big is the global Medical Wound Care Biologics market?
2. What is the demand of the global Medical Wound Care Biologics market?
3. What is the year over year growth of the global Medical Wound Care Biologics market?
4. What is the total value of the global Medical Wound Care Biologics market?
5. Who are the major players in the global Medical Wound Care Biologics market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Medical Wound Care Biologics Introduction
    1.2 World Medical Wound Care Biologics Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Medical Wound Care Biologics Total Market by Region (by Headquarter Location)
        1.3.1 World Medical Wound Care Biologics Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Medical Wound Care Biologics Market Size (2018-2029)
        1.3.3 China Medical Wound Care Biologics Market Size (2018-2029)
        1.3.4 Europe Medical Wound Care Biologics Market Size (2018-2029)
        1.3.5 Japan Medical Wound Care Biologics Market Size (2018-2029)
        1.3.6 South Korea Medical Wound Care Biologics Market Size (2018-2029)
        1.3.7 ASEAN Medical Wound Care Biologics Market Size (2018-2029)
        1.3.8 India Medical Wound Care Biologics Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Medical Wound Care Biologics Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Medical Wound Care Biologics Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Medical Wound Care Biologics Consumption Value (2018-2029)
    2.2 World Medical Wound Care Biologics Consumption Value by Region
        2.2.1 World Medical Wound Care Biologics Consumption Value by Region (2018-2023)
        2.2.2 World Medical Wound Care Biologics Consumption Value Forecast by Region (2024-2029)
    2.3 United States Medical Wound Care Biologics Consumption Value (2018-2029)
    2.4 China Medical Wound Care Biologics Consumption Value (2018-2029)
    2.5 Europe Medical Wound Care Biologics Consumption Value (2018-2029)
    2.6 Japan Medical Wound Care Biologics Consumption Value (2018-2029)
    2.7 South Korea Medical Wound Care Biologics Consumption Value (2018-2029)
    2.8 ASEAN Medical Wound Care Biologics Consumption Value (2018-2029)
    2.9 India Medical Wound Care Biologics Consumption Value (2018-2029)

3 World Medical Wound Care Biologics Companies Competitive Analysis
    3.1 World Medical Wound Care Biologics Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Medical Wound Care Biologics Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Medical Wound Care Biologics in 2022
        3.2.3 Global Concentration Ratios (CR8) for Medical Wound Care Biologics in 2022
    3.3 Medical Wound Care Biologics Company Evaluation Quadrant
    3.4 Medical Wound Care Biologics Market: Overall Company Footprint Analysis
        3.4.1 Medical Wound Care Biologics Market: Region Footprint
        3.4.2 Medical Wound Care Biologics Market: Company Product Type Footprint
        3.4.3 Medical Wound Care Biologics Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Medical Wound Care Biologics Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Medical Wound Care Biologics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Medical Wound Care Biologics Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Medical Wound Care Biologics Consumption Value Comparison
        4.2.1 United States VS China: Medical Wound Care Biologics Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Medical Wound Care Biologics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Medical Wound Care Biologics Companies and Market Share, 2018-2023
        4.3.1 United States Based Medical Wound Care Biologics Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Medical Wound Care Biologics Revenue, (2018-2023)
    4.4 China Based Companies Medical Wound Care Biologics Revenue and Market Share, 2018-2023
        4.4.1 China Based Medical Wound Care Biologics Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Medical Wound Care Biologics Revenue, (2018-2023)
    4.5 Rest of World Based Medical Wound Care Biologics Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Medical Wound Care Biologics Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Medical Wound Care Biologics Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Medical Wound Care Biologics Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Biologic Skin Substitutes
        5.2.2 Enzyme Based Formulations
        5.2.3 Growth Factors
    5.3 Market Segment by Type
        5.3.1 World Medical Wound Care Biologics Market Size by Type (2018-2023)
        5.3.2 World Medical Wound Care Biologics Market Size by Type (2024-2029)
        5.3.3 World Medical Wound Care Biologics Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Medical Wound Care Biologics Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Acute Wounds
        6.2.2 Chronic Wounds
        6.2.3 Surgical Wounds
    6.3 Market Segment by Application
        6.3.1 World Medical Wound Care Biologics Market Size by Application (2018-2023)
        6.3.2 World Medical Wound Care Biologics Market Size by Application (2024-2029)
        6.3.3 World Medical Wound Care Biologics Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Smith & Nephew Plc
        7.1.1 Smith & Nephew Plc Details
        7.1.2 Smith & Nephew Plc Major Business
        7.1.3 Smith & Nephew Plc Medical Wound Care Biologics Product and Services
        7.1.4 Smith & Nephew Plc Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Smith & Nephew Plc Recent Developments/Updates
        7.1.6 Smith & Nephew Plc Competitive Strengths & Weaknesses
    7.2 Stryker Corporation
        7.2.1 Stryker Corporation Details
        7.2.2 Stryker Corporation Major Business
        7.2.3 Stryker Corporation Medical Wound Care Biologics Product and Services
        7.2.4 Stryker Corporation Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Stryker Corporation Recent Developments/Updates
        7.2.6 Stryker Corporation Competitive Strengths & Weaknesses
    7.3 MIMEDX
        7.3.1 MIMEDX Details
        7.3.2 MIMEDX Major Business
        7.3.3 MIMEDX Medical Wound Care Biologics Product and Services
        7.3.4 MIMEDX Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 MIMEDX Recent Developments/Updates
        7.3.6 MIMEDX Competitive Strengths & Weaknesses
    7.4 Organogenesis
        7.4.1 Organogenesis Details
        7.4.2 Organogenesis Major Business
        7.4.3 Organogenesis Medical Wound Care Biologics Product and Services
        7.4.4 Organogenesis Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Organogenesis Recent Developments/Updates
        7.4.6 Organogenesis Competitive Strengths & Weaknesses
    7.5 Bioventus
        7.5.1 Bioventus Details
        7.5.2 Bioventus Major Business
        7.5.3 Bioventus Medical Wound Care Biologics Product and Services
        7.5.4 Bioventus Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Bioventus Recent Developments/Updates
        7.5.6 Bioventus Competitive Strengths & Weaknesses
    7.6 Skye Biologics
        7.6.1 Skye Biologics Details
        7.6.2 Skye Biologics Major Business
        7.6.3 Skye Biologics Medical Wound Care Biologics Product and Services
        7.6.4 Skye Biologics Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Skye Biologics Recent Developments/Updates
        7.6.6 Skye Biologics Competitive Strengths & Weaknesses
    7.7 Anika Therapeutics
        7.7.1 Anika Therapeutics Details
        7.7.2 Anika Therapeutics Major Business
        7.7.3 Anika Therapeutics Medical Wound Care Biologics Product and Services
        7.7.4 Anika Therapeutics Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Anika Therapeutics Recent Developments/Updates
        7.7.6 Anika Therapeutics Competitive Strengths & Weaknesses
    7.8 Alphatec Holdings
        7.8.1 Alphatec Holdings Details
        7.8.2 Alphatec Holdings Major Business
        7.8.3 Alphatec Holdings Medical Wound Care Biologics Product and Services
        7.8.4 Alphatec Holdings Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Alphatec Holdings Recent Developments/Updates
        7.8.6 Alphatec Holdings Competitive Strengths & Weaknesses
    7.9 Kerecis
        7.9.1 Kerecis Details
        7.9.2 Kerecis Major Business
        7.9.3 Kerecis Medical Wound Care Biologics Product and Services
        7.9.4 Kerecis Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Kerecis Recent Developments/Updates
        7.9.6 Kerecis Competitive Strengths & Weaknesses
    7.10 Integra LifeSciences
        7.10.1 Integra LifeSciences Details
        7.10.2 Integra LifeSciences Major Business
        7.10.3 Integra LifeSciences Medical Wound Care Biologics Product and Services
        7.10.4 Integra LifeSciences Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Integra LifeSciences Recent Developments/Updates
        7.10.6 Integra LifeSciences Competitive Strengths & Weaknesses
    7.11 Orthocell
        7.11.1 Orthocell Details
        7.11.2 Orthocell Major Business
        7.11.3 Orthocell Medical Wound Care Biologics Product and Services
        7.11.4 Orthocell Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Orthocell Recent Developments/Updates
        7.11.6 Orthocell Competitive Strengths & Weaknesses
    7.12 3M Company
        7.12.1 3M Company Details
        7.12.2 3M Company Major Business
        7.12.3 3M Company Medical Wound Care Biologics Product and Services
        7.12.4 3M Company Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 3M Company Recent Developments/Updates
        7.12.6 3M Company Competitive Strengths & Weaknesses
    7.13 Convatec Group
        7.13.1 Convatec Group Details
        7.13.2 Convatec Group Major Business
        7.13.3 Convatec Group Medical Wound Care Biologics Product and Services
        7.13.4 Convatec Group Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Convatec Group Recent Developments/Updates
        7.13.6 Convatec Group Competitive Strengths & Weaknesses
    7.14 Coloplast
        7.14.1 Coloplast Details
        7.14.2 Coloplast Major Business
        7.14.3 Coloplast Medical Wound Care Biologics Product and Services
        7.14.4 Coloplast Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Coloplast Recent Developments/Updates
        7.14.6 Coloplast Competitive Strengths & Weaknesses
    7.15 Cardinal Health
        7.15.1 Cardinal Health Details
        7.15.2 Cardinal Health Major Business
        7.15.3 Cardinal Health Medical Wound Care Biologics Product and Services
        7.15.4 Cardinal Health Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Cardinal Health Recent Developments/Updates
        7.15.6 Cardinal Health Competitive Strengths & Weaknesses
    7.16 Mölnlycke
        7.16.1 Mölnlycke Details
        7.16.2 Mölnlycke Major Business
        7.16.3 Mölnlycke Medical Wound Care Biologics Product and Services
        7.16.4 Mölnlycke Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 Mölnlycke Recent Developments/Updates
        7.16.6 Mölnlycke Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Medical Wound Care Biologics Industry Chain
    8.2 Medical Wound Care Biologics Upstream Analysis
    8.3 Medical Wound Care Biologics Midstream Analysis
    8.4 Medical Wound Care Biologics Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Medical Wound Care Biologics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Medical Wound Care Biologics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Medical Wound Care Biologics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Medical Wound Care Biologics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Medical Wound Care Biologics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Medical Wound Care Biologics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Medical Wound Care Biologics Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Medical Wound Care Biologics Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Medical Wound Care Biologics Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Medical Wound Care Biologics Players in 2022
    Table 12. World Medical Wound Care Biologics Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Medical Wound Care Biologics Company Evaluation Quadrant
    Table 14. Head Office of Key Medical Wound Care Biologics Player
    Table 15. Medical Wound Care Biologics Market: Company Product Type Footprint
    Table 16. Medical Wound Care Biologics Market: Company Product Application Footprint
    Table 17. Medical Wound Care Biologics Mergers & Acquisitions Activity
    Table 18. United States VS China Medical Wound Care Biologics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Medical Wound Care Biologics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Medical Wound Care Biologics Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Medical Wound Care Biologics Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Medical Wound Care Biologics Revenue Market Share (2018-2023)
    Table 23. China Based Medical Wound Care Biologics Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Medical Wound Care Biologics Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Medical Wound Care Biologics Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Medical Wound Care Biologics Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Medical Wound Care Biologics Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Medical Wound Care Biologics Revenue Market Share (2018-2023)
    Table 29. World Medical Wound Care Biologics Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Medical Wound Care Biologics Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Medical Wound Care Biologics Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Medical Wound Care Biologics Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Medical Wound Care Biologics Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Medical Wound Care Biologics Market Size by Application (2024-2029) & (USD Million)
    Table 35. Smith & Nephew Plc Basic Information, Area Served and Competitors
    Table 36. Smith & Nephew Plc Major Business
    Table 37. Smith & Nephew Plc Medical Wound Care Biologics Product and Services
    Table 38. Smith & Nephew Plc Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Smith & Nephew Plc Recent Developments/Updates
    Table 40. Smith & Nephew Plc Competitive Strengths & Weaknesses
    Table 41. Stryker Corporation Basic Information, Area Served and Competitors
    Table 42. Stryker Corporation Major Business
    Table 43. Stryker Corporation Medical Wound Care Biologics Product and Services
    Table 44. Stryker Corporation Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Stryker Corporation Recent Developments/Updates
    Table 46. Stryker Corporation Competitive Strengths & Weaknesses
    Table 47. MIMEDX Basic Information, Area Served and Competitors
    Table 48. MIMEDX Major Business
    Table 49. MIMEDX Medical Wound Care Biologics Product and Services
    Table 50. MIMEDX Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. MIMEDX Recent Developments/Updates
    Table 52. MIMEDX Competitive Strengths & Weaknesses
    Table 53. Organogenesis Basic Information, Area Served and Competitors
    Table 54. Organogenesis Major Business
    Table 55. Organogenesis Medical Wound Care Biologics Product and Services
    Table 56. Organogenesis Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Organogenesis Recent Developments/Updates
    Table 58. Organogenesis Competitive Strengths & Weaknesses
    Table 59. Bioventus Basic Information, Area Served and Competitors
    Table 60. Bioventus Major Business
    Table 61. Bioventus Medical Wound Care Biologics Product and Services
    Table 62. Bioventus Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Bioventus Recent Developments/Updates
    Table 64. Bioventus Competitive Strengths & Weaknesses
    Table 65. Skye Biologics Basic Information, Area Served and Competitors
    Table 66. Skye Biologics Major Business
    Table 67. Skye Biologics Medical Wound Care Biologics Product and Services
    Table 68. Skye Biologics Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Skye Biologics Recent Developments/Updates
    Table 70. Skye Biologics Competitive Strengths & Weaknesses
    Table 71. Anika Therapeutics Basic Information, Area Served and Competitors
    Table 72. Anika Therapeutics Major Business
    Table 73. Anika Therapeutics Medical Wound Care Biologics Product and Services
    Table 74. Anika Therapeutics Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Anika Therapeutics Recent Developments/Updates
    Table 76. Anika Therapeutics Competitive Strengths & Weaknesses
    Table 77. Alphatec Holdings Basic Information, Area Served and Competitors
    Table 78. Alphatec Holdings Major Business
    Table 79. Alphatec Holdings Medical Wound Care Biologics Product and Services
    Table 80. Alphatec Holdings Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Alphatec Holdings Recent Developments/Updates
    Table 82. Alphatec Holdings Competitive Strengths & Weaknesses
    Table 83. Kerecis Basic Information, Area Served and Competitors
    Table 84. Kerecis Major Business
    Table 85. Kerecis Medical Wound Care Biologics Product and Services
    Table 86. Kerecis Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Kerecis Recent Developments/Updates
    Table 88. Kerecis Competitive Strengths & Weaknesses
    Table 89. Integra LifeSciences Basic Information, Area Served and Competitors
    Table 90. Integra LifeSciences Major Business
    Table 91. Integra LifeSciences Medical Wound Care Biologics Product and Services
    Table 92. Integra LifeSciences Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Integra LifeSciences Recent Developments/Updates
    Table 94. Integra LifeSciences Competitive Strengths & Weaknesses
    Table 95. Orthocell Basic Information, Area Served and Competitors
    Table 96. Orthocell Major Business
    Table 97. Orthocell Medical Wound Care Biologics Product and Services
    Table 98. Orthocell Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Orthocell Recent Developments/Updates
    Table 100. Orthocell Competitive Strengths & Weaknesses
    Table 101. 3M Company Basic Information, Area Served and Competitors
    Table 102. 3M Company Major Business
    Table 103. 3M Company Medical Wound Care Biologics Product and Services
    Table 104. 3M Company Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. 3M Company Recent Developments/Updates
    Table 106. 3M Company Competitive Strengths & Weaknesses
    Table 107. Convatec Group Basic Information, Area Served and Competitors
    Table 108. Convatec Group Major Business
    Table 109. Convatec Group Medical Wound Care Biologics Product and Services
    Table 110. Convatec Group Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Convatec Group Recent Developments/Updates
    Table 112. Convatec Group Competitive Strengths & Weaknesses
    Table 113. Coloplast Basic Information, Area Served and Competitors
    Table 114. Coloplast Major Business
    Table 115. Coloplast Medical Wound Care Biologics Product and Services
    Table 116. Coloplast Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Coloplast Recent Developments/Updates
    Table 118. Coloplast Competitive Strengths & Weaknesses
    Table 119. Cardinal Health Basic Information, Area Served and Competitors
    Table 120. Cardinal Health Major Business
    Table 121. Cardinal Health Medical Wound Care Biologics Product and Services
    Table 122. Cardinal Health Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Cardinal Health Recent Developments/Updates
    Table 124. Mölnlycke Basic Information, Area Served and Competitors
    Table 125. Mölnlycke Major Business
    Table 126. Mölnlycke Medical Wound Care Biologics Product and Services
    Table 127. Mölnlycke Medical Wound Care Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 128. Global Key Players of Medical Wound Care Biologics Upstream (Raw Materials)
    Table 129. Medical Wound Care Biologics Typical Customers
List of Figure
    Figure 1. Medical Wound Care Biologics Picture
    Figure 2. World Medical Wound Care Biologics Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Medical Wound Care Biologics Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Medical Wound Care Biologics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Medical Wound Care Biologics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Medical Wound Care Biologics Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Medical Wound Care Biologics Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Medical Wound Care Biologics Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Medical Wound Care Biologics Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Medical Wound Care Biologics Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Medical Wound Care Biologics Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Medical Wound Care Biologics Revenue (2018-2029) & (USD Million)
    Figure 13. Medical Wound Care Biologics Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Medical Wound Care Biologics Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Medical Wound Care Biologics Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Medical Wound Care Biologics Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Medical Wound Care Biologics Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Medical Wound Care Biologics Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Medical Wound Care Biologics Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Medical Wound Care Biologics Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Medical Wound Care Biologics Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Medical Wound Care Biologics Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Medical Wound Care Biologics by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Medical Wound Care Biologics Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Medical Wound Care Biologics Markets in 2022
    Figure 27. United States VS China: Medical Wound Care Biologics Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Medical Wound Care Biologics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Medical Wound Care Biologics Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Medical Wound Care Biologics Market Size Market Share by Type in 2022
    Figure 31. Biologic Skin Substitutes
    Figure 32. Enzyme Based Formulations
    Figure 33. Growth Factors
    Figure 34. World Medical Wound Care Biologics Market Size Market Share by Type (2018-2029)
    Figure 35. World Medical Wound Care Biologics Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Medical Wound Care Biologics Market Size Market Share by Application in 2022
    Figure 37. Acute Wounds
    Figure 38. Chronic Wounds
    Figure 39. Surgical Wounds
    Figure 40. Medical Wound Care Biologics Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Companies Mentioned

Smith & Nephew Plc
Stryker Corporation
MIMEDX
Organogenesis
Bioventus
Skye Biologics
Anika Therapeutics
Alphatec Holdings
Kerecis
Integra LifeSciences
Orthocell
3M Company
Convatec Group
Coloplast
Cardinal Health
Mölnlycke